Cambridge Investment Research Advisors, Inc. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$7
-99.9%
66,754
-9.6%
0.00%
Q3 2022$12,000
-36.8%
73,819
+0.5%
0.00%
Q2 2022$19,000
-52.5%
73,419
-1.3%
0.00%
Q1 2022$40,000
-43.7%
74,419
-35.8%
0.00%
Q4 2021$71,000
-23.7%
115,919
+27.5%
0.00%
Q3 2021$93,000
-44.0%
90,919
+0.2%
0.00%
-100.0%
Q2 2021$166,000
-6.2%
90,764
+1.2%
0.00%0.0%
Q1 2021$177,000
+42.7%
89,699
-9.4%
0.00%0.0%
Q4 2020$124,000
-41.8%
99,049
-16.3%
0.00%0.0%
Q3 2020$213,000
-61.5%
118,335
+79.6%
0.00%
-75.0%
Q2 2020$553,000
+119.4%
65,899
+37.1%
0.00%
+100.0%
Q1 2020$252,000
-5.3%
48,079
-1.4%
0.00%0.0%
Q4 2019$266,000
+10.4%
48,744
-1.6%
0.00%0.0%
Q3 2019$241,000
-28.3%
49,544
+2.2%
0.00%
-33.3%
Q2 2019$336,0000.0%48,494
+0.5%
0.00%0.0%
Q1 2019$336,000
+20.9%
48,274
+1.6%
0.00%0.0%
Q4 2018$278,000
+2.6%
47,534
+32.5%
0.00%0.0%
Q3 2018$271,000
+127.7%
35,884
+52.7%
0.00%
+200.0%
Q2 2018$119,000
-45.7%
23,504
-34.6%
0.00%
-50.0%
Q1 2018$219,000
+14.7%
35,954
+33.6%
0.00%0.0%
Q4 2017$191,000
+0.5%
26,904
+1.1%
0.00%
-33.3%
Q3 2017$190,00026,6240.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders